Dr James Goldring trained at the London Chest, Royal Brompton and UCL Hospitals before being appointed consultant in respiratory and general medicine to the Royal Free in 2011. In addition he holds appointments as Clinical Associate Professor at UCL and Medical Examiner.

Dr Goldring is research active and has published widely including in: covid-19, pleural disease, lung cancer, COPD, bronchoscopy and non-invasive ventilation. Outside of work he enjoys campervanning with his family and growing produce on their allotment.

Special interests

  • General respiratory medicine and acute medicine.
  • Unexplained breathlessness.
  • Cardiopulmonary exercise testing.
  • Bronchoscopy, EBUS and pleural disease.



GMC number


  • Knight DS, Kotecha T, Razvi Y, Chacko L, Brown JT, Jeetley PS, Goldring J, Jacobs M, Lamb LE, Negus R, Wolff A, Moon JC, Xue H, Kellman P, Patel N, Fontana M. COVID-19: Myocardial Injury in Survivors. Circulation. 2020; 142(11):1120-1122
  • Walker SP, Keenan E, Bintcliffe O, Stanton AE, Roberts M, Pepperell J, Fairbairn I, McKeown E, Goldring J, Maddekar N, Walters J, West A, Bhatta A, Knight M, Mercer R, Hallifax R, White P, Miller RF, Rahman NM, Maskell NA. Ambulatory management of secondary spontaneous pneumothorax: a randomised controlled trial. Eur Respir J. 2020 Dec 17:2003375
  • Yang DD, Mirvis E, Goldring J, Patel ARC, Wagner T. Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer. Clin Radiol. 2019; 74(10):818
  • Polverino F, Rojas-Quintero J, Wang X, Petersen H, Zhang L, Gai X, Higham A, Zhang D, Gupta K, Rout A, Yambayev I, Pinto-Plata V, Sholl LM, Cunoosamy D, Celli BR, Goldring J, Singh D, Tesfaigzi Y, Wedzicha J, Olsson H, Owen CA. A Disintegrin and A Metalloproteinase Domain-8 (ADAM8): A Novel Protective Proteinase in COPD. Am J Respir Crit Care Med. 2018;198:1254
  • Mallorie A, Goldring J, Patel A, Lim E, Wagner T. Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity. Nucl Med Commun. 2017;38:715
  • Steel A, Goldring J. End-of-life care in patients with chronic obstructive pulmonary disease. Br J Hosp Med. 2015;76:10